The Jack & Jill Last Stage Cancer Foundation (JAJF) merits praise for being a different kind of philanthropy—one that treats the families not the cancer. For Oncologists to now "prescribe" JAJF as part of the treatment protocol for the patient, the spouse and their children…the family together is extraordinary. Oncologists have validated the medicinal impact JAJF is having in the immediate term and now longer term years later for these families.

The following message from the American Cancer Society demonstrates JAJF’s measurable and meaningful impact on families coping with late stage cancer:

Jon,
I wish you and your family well. We were able to get some data for you.

We can expect about 9652 new cases of late stage cancer annually in the 28-50 population, 4177 in males and 5475 females. With that in mind, there is a total potential of 4500- 6000 annually for the Jack and Jill Late Stage Cancer Foundation to serve (when coupled with the existing cases). An incredible, albeit sobering, opportunity. The foundation will continue to make a tangible, important impact nationally.

PPH
Patricia P. Hoge RN PhD
Chief Mission Officer American Cancer Society

The average cost to JAJF to treat a family of 4 to 6 to a fabulous (complete) WOW! Experience is $1400. We leverage our in-kind partnerships and send families on their cherished timeout from late stage cancer. These smiles; the meaningful, measurable (lasting) impact is what our supporters call their return on their investment. There is no black hole.

Ask how you can also receive the letters from your families, their sweet pictures and even talk with or meet the families you “treat”.